Acute leukemia and stem cell transplantation

Authors

  • Janina Georgiana Goanta Filantropia Hospital. Department of Hematology, Craiova

DOI:

https://doi.org/10.52701/monc.2021.v2i1.31

Keywords:

acute leukemia, stem cell transplantation

Abstract

Acute leukemias are a type of clonal proliferative malignancies that affect all ages with a predominance of ALL in children and AML in adults. Left untreated they are lethal and require rapid medical management. Not only it imposes high health risks through complications such as infections, but the treatment itself is also a source of potential risks. Acute leukemias require intense medical observation and care. Current treatment consists of a combination of chemotherapeutic agents, stem cell transplantation and supportive care. Recent research offers a better understanding of the pathogenesis of these diseases and provide an advancement in the field of targeted therapeutic agents.

References

Kayser S, Levis MJ. Advances in targeted therapy for acute myeloid leukaemia. British journal of haematology. 2018;180(4):484-500.

https://doi.org/10.1111/bjh.15032

Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA: a cancer journal for clinicians. 1994;44(6):326-52.

https://doi.org/10.3322/canjclin.44.6.326

Forestier E, Schmiegelow K. The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. Journal of pediatric hematology/oncology. 2006;28(8):486-95.

https://doi.org/10.1097/01.mph.0000212972.90877.28

Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children: Current status and future directions. Pediatrics International. 2016;58(2):71-80.

https://doi.org/10.1111/ped.12865

Estey E, Döhner H. Acute myeloid leukaemia. The Lancet. 2006;368(9550):1894-907.

https://doi.org/10.1016/S0140-6736(06)69780-8

Rashidi A, Weisdorf DJ, Bejanyan N. Treatment of relapsed/refractory acute myeloid leukaemia in adults. British journal of Haematology. 2018;181(1):27-37.

https://doi.org/10.1111/bjh.15077

Hasserjian RP, Steensma DP, Graubert TA, Ebert BL. Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia. blood. 2020;135(20):1729-38.

https://doi.org/10.1182/blood.2019004770

Takami A. Hematopoietic stem cell transplantation for acute myeloid leukemia. International journal of hematology. 2018;107(5):513-8.

https://doi.org/10.1007/s12185-018-2412-8

Zittoun RA, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New England Journal of Medicine. 1995;332(4):217-23.

https://doi.org/10.1056/NEJM199501263320403

Pelcovits A, Niroula R. Acute Myeloid leukemia: A review. Rhode Island Medical Journal. 2020;103(3):38-40.

Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees JK, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. The Lancet. 1998;351(9104):700-8.

https://doi.org/10.1016/S0140-6736(97)09214-3

Medinger M, Lengerke C, Passweg J. Novel therapeutic options in acute myeloid leukemia. Leukemia research reports. 2016;6:39-49.

https://doi.org/10.1016/j.lrr.2016.09.001

Ozdemir ZN, Bozda? SC. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfusion and Apheresis Science. 2018;57(2):163-7.

https://doi.org/10.1016/j.transci.2018.04.014

Kassim AA, Savani BN. Hematopoietic stem cell transplantation for acute myeloid leukemia: a review. Hematology/oncology and stem cell therapy. 2017;10(4):245-51.

https://doi.org/10.1016/j.hemonc.2017.05.021

Kembhavi SA, Somvanshi S, Banavali S, Kurkure P, Arora B. Pictorial essay: Acute neurological complications in children with acute lymphoblastic leukemia. The Indian journal of radiology & imaging. 2012;22(2):98.

https://doi.org/10.4103/0971-3026.101080

Seth R, Singh A. Leukemias in children. The Indian Journal of Pediatrics. 2015;82(9):817-24.

https://doi.org/10.1007/s12098-015-1695-5

Hallböök H, Gustafsson G, Smedmyr B, Söderhäll S, Heyman M, Group SAALL, et al. Treatment outcome in young adults and children> 10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer. 2006;107(7):1551-61.

https://doi.org/10.1002/cncr.22189

Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet journal of rare diseases. 2007;2(1):1-9.

https://doi.org/10.1186/1750-1172-2-1

Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft?versus?host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101(9):1936-46.

https://doi.org/10.1002/cncr.20613

Babak S, Korzhenkov A, Samarov N, Boichenko E, Goeva M, Voloshina AY, et al. Adverse side effects of anticancer drugs in treatment of children with acute lymphoblastic leukemia. Voprosy onkologii. 2016;62(5):596-605.

Amouzegar A, Dey BR, Spitzer TR. Peripheral Blood or bone marrow stem cells? Practical Considerations in hematopoietic stem cell transplantation. Transfusion medicine reviews. 2019;33(1):43-50.

https://doi.org/10.1016/j.tmrv.2018.11.003

Lou X, Zhao C, Chen H. Unrelated donor umbilical cord blood transplant versus unrelated hematopoietic stem cell transplant in patients with acute leukemia: A meta-analysis and systematic review. Blood reviews. 2018;32(3):192-202.

https://doi.org/10.1016/j.blre.2017.11.003

Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, et al. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. Leukemia. 2014;28(4):779-86.

https://doi.org/10.1038/leu.2013.259

Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada Y, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood. 2004;103(2):489-91.

https://doi.org/10.1182/blood-2003-07-2420

Downloads

Published

2021-05-25